|
End-of-day quote
Buenos Aires S.E.
28/08/2026
|
5-day change | 1st Jan Change | ||
| 65,275.00 ARS | -1.02% |
|
-1.43% | -7.48% |
| 11:53am | IDEAYA Biosciences Plans Phase 3 Trial for Lung Cancer Therapy | MT |
| 08:39am | Hutchmed Says Lung Cancer Therapy Improves Progression-Free Survival in China Phase 3 Trial | MT |
Stock exchange
Buenos Aires S.E.
AZN 65,275.00 $
-1.02%
359M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| AZN | 163.30USD | +0.37% | 51.29M $ | ||
| AZN | 11,970.00GBX | -1.19% | 36.26B p | ||
NYSE
| AZN | 162.70USD | -1.11% | 469M $ | |
|
CBOE
| AZN | 11,994.00GBX | -1.24% | 5.52B p | |
|
Nasdaq Stockholm
| AZN | 1,566.00SEK | +0.45% | 336M kr | |
|
CBOE
| AZNs | 1,570.25SEK | +0.69% | 181M kr | |
|
CBOE
| AZN | 163.73USD | +0.64% | 1.8M $ | |
|
Tradegate
| ZEG | 140.70EUR | +0.18% | 459K € | |
|
Mexican S.E.
| AZN1 N | 2,717.48MXN | +0.68% | 4.2M $ | |
|
CBOE
| AZN | 1,561.50SEK | +0.42% | 645K kr | |
|
Boerse Muenchen
| ZEG | 141.10EUR | +0.68% | 42.47K € | |
|
Börse Stuttgart
| ZEG | 140.30EUR | +0.04% | 23.71K € | |
|
Deutsche Boerse AG
| ZEG | 139.60EUR | -1.90% | 23.31K € | |
|
Berne S.E.
| 000982352 | 132.24CHF | +0.75% | 132.24 CHF | |
| AZN | 65,275.00ARS | -1.02% | 359M $ | ||
|
Buenos Aires S.E.
| AZND | 42.60USD | -0.93% | 3.11K $ | |
| A1ZN34 | 140.13BRL | -1.57% | 9.39K R$ |
Quotes 5-day view: AstraZeneca PLC
End-of-day quote Buenos Aires S.E.| 24/08/2026 | 25/08/2026 | 26/08/2026 | 27/08/2026 | 28/08/2026 | |
|---|---|---|---|---|---|
| Last | ARS 66,800.00 | ARS 67,800.00 | ARS 66,850.00 | ARS 65,950.00 | ARS 65,275.00 |
| Volume | 636 | 942 | 976 | 2,552 | 5,493 |
| Change | +0.87% | +1.50% | -1.40% | -1.35% | -1.02% |
| Opening | ARS 65,625.00 | ARS 66,800.00 | ARS 67,125.00 | ARS 66,575.00 | ARS 65,325.00 |
| High | ARS 66,825.00 | ARS 68,000.00 | ARS 67,125.00 | ARS 66,575.00 | ARS 65,675.00 |
| Low | ARS 65,400.00 | ARS 66,800.00 | ARS 66,325.00 | ARS 65,775.00 | ARS 64,750.00 |
Performance
| 1 day | -1.02% | ||
| 1 week | -1.43% | ||
| Current month | -2.54% | ||
| 1 month | -2.61% | ||
| 3 months | -5.19% | ||
| 6 months | -12.97% | ||
| Current year | -7.48% | ||
| 1 year | +20.88% | ||
| 3 years | +136.74% | ||
| 5 years | +1,169.94% | ||
| 10 years | +65,901.01% |
Volumes
marketsDaily volume
5,493
Avg. Volume 20 sessions
1,788
Avg. Volume 20 sessions ARS
116,711,700
Avg. Volume 20 sessions USD
77,263.15
Record volume 1
40,104
Record volume 2
23,190
Record volume 3
23,100
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (ARS)
251,732,324,102
Market Cap (USD)
251,732,324,102
Net sales (USD)
58,739,000,000
Number of employees
96,100
Sales / Employee (USD)
611,228
Free-Float
96.63 %
Free-Float capitalization (ARS)
160,704,777
Free-Float capitalization (USD)
243,242,749,945
Average Daily Capital Traded
0.05%
Indicators
Moving average 5 days
66,535
Moving average 20 days
64,396.25
Moving average 50 days
67,496.5
Moving average 100 days
68,802.75
Price spread / (MMA5)
+1.93%
Price spread / (MMA20)
-1.35%
Price spread / (MMA50)
+3.40%
Price spread / (MMA100)
+5.40%
RSI 9 days
48.93
RSI 14 days
48.32
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.02% | -1.43% | +20.88% | +136.74% | 252B | |
| -1.37% | -7.68% | +56.57% | +107.71% | 1,047B | |
| -0.24% | -1.99% | +50.29% | +65.52% | 646B | |
| +0.27% | -3.81% | +20.06% | +73.13% | 451B | |
| -1.60% | -4.64% | +35.74% | +35.69% | 355B | |
| -0.42% | -2.87% | +21.25% | +37.86% | 291B | |
| -1.19% | -2.21% | +1.53% | +11.51% | 252B | |
| -0.19% | -2.95% | +50.13% | +68.04% | 234B | |
| -1.09% | -2.67% | -20.23% | -54.28% | 203B | |
| -0.94% | -2.04% | +27.54% | +87.96% | 181B | |
| Average | -0.82% | -2.68% | +26.38% | +56.99% | 391.1B | |
| Weighted average by Cap. | -0.85% | -3.46% | +35.25% | +69.01% |
Historical Quotes: AstraZeneca PLC
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 1 week | 64,750 |  | 68,000 |
| 1 month | 60,650 | | 68,000 |
| Current year | 60,650 | | 80,275 |
| 1 year | 50,650 | | 80,275 |
| 3 years | 24,182 | | 80,275 |
| 5 years | 4,889 | | 80,275 |
| 10 years | 214.5 | | 80,275 |
Monthly variations
Annual variations
| 2026 | -7.48% | ||
| 2025 | +81.13% | ||
| 2024 | +19.30% | ||
| 2023 | +183.89% | ||
| 2022 | +95.60% | ||
| 2021 | +63.33% | ||
| 2020 | +1,578.32% | ||
| 2017 | +116.89% | ||
| 2010 | +35.29% | ||
| 2007 | -18.60% | ||
| 2006 | +19.65% | ||
| 2005 | +39.76% | ||
| 2004 | -22.51% | ||
| 2003 | 0.00% |
- Stock Market
- Stocks
- AZN Stock
- AZN Stock
- Quotes AstraZeneca PLC
Select your edition
All financial news and data tailored to specific country editions
